Pre(peri)-natal ω-3 PUFA deficiency-induced hypertension and its broader implications

Hypertension Research

Volumn 35, Issue 4, 2012, Pages 375-379

  Das, Undurti N ^a,b,c  

^a UND LIFE SCIENCES   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; DOPAMINE 3 RECEPTOR; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; BLOOD PRESSURE; DIET SUPPLEMENTATION; ESSENTIAL FATTY ACID DEFICIENCY; ESSENTIAL HYPERTENSION; FATTY ACID METABOLISM; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MALIGNANT HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; ONSET AGE; PRENATAL PERIOD; STROKE; VASCULAR RESISTANCE; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; FATTY ACIDS, OMEGA-3; GENE EXPRESSION; HYPERTENSION; HYPOTHALAMUS; MALE;

EID: 84859582987     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.225     Document Type: Note

References (43)

1. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: The Women's Health Study. Eur Heart J 2007; 28: 2937-2943. (Pubitemid 350233022)
2. Das UN. Essential fatty acids and their metabolites in the context of hypertension. Hypertens Res 2010; 33: 782-785.
3. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Med Clin North Am 2011; 95: 875-892.
4. O'Rahilly S, Hattersley A, Vaag A, Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophecy? Lancet 1994; 344: 585-589. (Pubitemid 24267219)
5. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005; 109: 143-159. (Pubitemid 41117297)
6. Rajkumar C, Mensah R, Meeran K, Armstrong S, Bulpitt CJ. Peripheral arterial compliance is lower in Afro-Caribbeans compared to white Caucasians with type 2 diabetes after adjustment for blood pressure. J Hum Hypertens 1999; 13: 841-843. (Pubitemid 30028950)
7. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011; 123: 1940-1946.
8. Park S, Ahn IS, Kim da S. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model. Life Sci 2010; 86: 854-862.
9. Savoy YE, Ashton MA, Miller MW, Nedza FM, Spracklin DK, Hawthorn MH, Rollema H, Matos FF, Hajos-Korcsok E. Differential effects of various typical and atypical antipsychotics on plasma glucose and insulin levels in the mouse: evidence for the involvement of sympathetic regulation. Schizophr Bull 2010; 36: 410-418.
10. Esler M. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol 2011; 96: 611-622.
11. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010; 56: 351-358.
12. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radical Res Commun 1993; 19: 59-66. (Pubitemid 23310628)
13. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-b to prevent human essential hypertension. Eur J Clin Nutr 2003; 58 (2): 195-203. (Pubitemid 38256571)
14. Suryaprabha P, Das UN et al. Free Radicals, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension. Prostaglandins Leukot Essen Fatty Acids 1990; 41: 27-33. (Pubitemid 20284955)
15. Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006; 26: 1215-1225. (Pubitemid 44305364)
16. Ozkor MA, Quyyumi AA. Endothelium-derived hyperpolarizing factor and vascular function. Cardiol Res Pract 2011; 2011: 156146.
17. Fleming I. Epoxyeicosatrienoic acids, cell signaling and angiogenesis. Prostaglandins Other Lipid Mediat 2007; 82: 60-67. (Pubitemid 44880162)
18. Arnold C, Konkel A, Fischer R, Schunck W-H. Cytochrome P450-dependent metabolism of ω-6 and ω-3 long-chain polyunsaturated fatty acids. Pharmacological Rep 2010; 62: 536-547.
19. Fer M, Dréano Y, Lucas D, Corcos L, Salaün J-P, Berthou F, Amet Y. Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 2008; 471: 116-125.
20. Fer M, Corcos L, Dréano Y, Plée-Gautier E, Salaün J-P, Berthou F, Amet Y. Cytochromes P450 from family 4 are the main omega hydroxylating enzymes in humans: CYP4F3B is the prominent player in PUFA metabolism. J Lipid Res 2008; 49: 2379-2389.
21. Arnold C, Markovic M, Blossey K, Wallukat G, Fischer R, Dechend R, Konkel A, von Schacky C, Luft FC, Muller DN, Rothe M, Schunck WH. Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids. J Biol Chem 2010; 285: 32720-32733.
22. Begg DP, Puskás LG, Kitajka K, Ménesi D, Allen AM, Li D, Mathai ML, Shi JR, Sinclair AJ, Weisinger RS. Hypothalamic gene expression in ω-3 PUFA-deficient male rats before, and following, development of hypertension. Hypertens Res 2012; 35: 381-387.
23. Weisinger HS, Armitage JA, Sinclair AJ, Vingrys AJ, Burns PL, Weisinger RS. Perinatal omega-3 fatty acid deficiency affects blood pressure later in life. Nat Med 2001; 7: 258-259. (Pubitemid 32224317)
24. Li D, Weisinger HS, Weisinger RS, Mathai M, Armitage JA, Vingrys AJ, Sinclair AJ. Omega 6 to omega 3 fatty acid imbalance early in life leads to persistent reductions in DHA levels in glycerophospholipids in rat hypothalamus even after long-term omega 3 fatty acid repletion. Prostaglandins Leukot Essent Fatty Acids 2006; 74: 391-399. (Pubitemid 43816852)
25. Begg DP, Sinclair AJ, Stahl LA, Premaratna SD, Hafandi A, Jois M, Weisinger RS. Hypertension induced by o-3 polyunsaturated fatty acid deficiency is alleviated by a-linolenic acid regardless of dietary source. Hypertens Res 2010; 33: 808-813.
26. Armitage JA, Pearce AD, Sinclair AJ, Vingrys AJ, Weisinger RS, Weisinger HS. Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency. Lipids 2003; 38: 459-464.
27. Begg DP, Sinclair AJ, Stahl LA, Garg ML, Jois M, Weisinger RS. Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension. Am J Hypertens 2010; 23: 125-128.
28. Mitasikova M, Smidova S, Macsaliova A, Knezl V, Dlugosova K, Okruhlicova L, Weismann P, Tribulova N. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol Res 2008; 57(Suppl 2): S39-S48.
29. Forsyth JS, Willatts P, Agostoni C, Bissenden J, Casaer P, Boehm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial. BMJ 2003; 326: 953.
30. Taittonen L, Nuutinen M, Turtinen J, Uhari M. Perinatal factors in predicting later blood pressure among children: cardiovascular risk in young Finns. Pediatr Res 1996; 40: 627-632. (Pubitemid 26332593)
31. Wilson AC, Forsyth JS, Greene SA, Irvine L, Hau C, Howie PW. Relation of infant diet to childhood health: seven year follow up of cohort in Dundee infant feeding study. BMJ 1998; 316: 21-25. (Pubitemid 28019864)
32. Singhal A, Cole TJ, Lucas A. Early nutrition in preterm infants and later blood pressure: two cohorts after randomized trials. Lancet 2001; 357: 413-419. (Pubitemid 32156138)
33. Baur LA, O'Connor J, Pan DA, Kriketos AD, Storlien LH. The fatty acid composition of skeletal muscle membrane phospholipids: its relationship with the type of feeding and plasma glucose levels in young children. Metabolism 1998; 47: 106-112. (Pubitemid 28086242)
34. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-b to prevent human essential hypertension. Eur J Clin Nutr 2003; 58: 195-203. (Pubitemid 38256571)
35. Das UN. Hypertension as a low-grade systemic inflammatory condition that has its origins in the perinatal period. J Assoc Physicians India 2006; 54: 133-142. (Pubitemid 43200704)
36. Arun Kumar C, Das UN. Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Med Sci Monitor 2000; 6: 901-907.
37. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001; 17: 337-346. (Pubitemid 32454988)
38. Das UN, Repossi G, Dain A, Eynard AR. L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes. Frontiers BioSci 2011; 16: 13-20.
39. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001; 50: 2384-2389. (Pubitemid 33641926)
40. Das UN. Risk of type 2 diabetes mellitus in those with hypertension. Eur Heart J 2008; 29: 952-953. (Pubitemid 351499484)
41. Das UN. Molecular Basis of Health and Disease. Springer: New York, 2011.
42. Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids: Connecting lipids, inflammation, and cardiovascular disease risk. Current Cardiovasc Risk Rep 2010; 4: 24-31.
43. Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis 2011; 10: 76.